Results for tag: "Salmeterol"

Salmeterol is a long-acting β2-adrenergic receptor agonist (LABA) used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is used as a bronchodilator to relax the muscles in the airways and increase airflow to the lungs. Salmeterol is typically used in combination with an inhaled corticosteroid (ICS) to provide long-term control of asthma symptoms. It is also used as a rescue medication for the relief of acute asthma symptoms. Salmeterol is available in a variety of formulations, including metered-dose inhalers, dry powder inhalers, and nebulizers. It is also available in combination with other drugs, such as fluticasone, formoterol, and budesonide. The Salmeterol market is a part of the larger respiratory drugs market, which includes drugs used to treat a variety of respiratory conditions, such as asthma, COPD, and cystic fibrosis. The market is driven by factors such as increasing prevalence of respiratory diseases, rising demand for combination therapies, and the introduction of new drugs. Some of the major companies in the Salmeterol market include GlaxoSmithKline, Merck & Co., Novartis, Teva Pharmaceuticals, and Mylan. Show Less Read more